Renata Beck

Dr. Renata Beck

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2018
Verified
Journal Article
Closed access
DBDomenico Baldini
Domenico Baldini
MSM. V. Savoia
M. V. Savoia
ASA. G. Sciancalepore
A. G. Sciancalepore
AMA. Malvasi
A. Malvasi
DVD. Vizziello
D. Vizziello
GVG. Vizziello
G. Vizziello

1 April 2018 in Minerva Anestesiologica
Verified
Journal Article
Closed access
ACAntonella Cotoia
Antonella Cotoia
LMLucia Mirabella
Lucia Mirabella
RBRenata Beck
Renata Beck
PMPompeo Matrella
Pompeo Matrella
VAValentina Assenzo
Valentina Assenzo
MDMichele Dambrosio
Michele Dambrosio
Article: Effects of closed-loop intravenous anesthesia guided by Bispectral Index in adult patients on emergence delirium: a randomized controlled study - Minerva Anestesiologica 2018 April;84(4):437-46 - Minerva Medica - Journals

1 April 2022 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Simona ZaamiSimona Zaami
Simona Zaami
SGSilvia Graziano
Silvia Graziano
RTRoberta Tittarelli
Roberta Tittarelli
RBRenata Beck
Renata Beck
Enrico MartinelliEnrico Martinelli
Enrico Martinelli
: Benzodiazepines (BZDs) are a widely prescribed class of sedative-hypnotics compounds for the treatment of a broad range of conditions as anxiety and obsessive-compulsive disorders, phobias, sleep-related problems associated with insomnia, and for the management of alcohol and GHB withdrawal. Zolpidem, zopiclone and zaleplon, commonly known as Z-drugs, are non-benzodiazepine hypnotic drugs with pharmacology similar to BDZs. Despite their usefulness, BDZs and Z-drugs present a potential for abuse and dependence. Moreover, the non-medical use of BDZs is a well-known phenomenon and represents an increasingly widespread public health problem since it is associated with an elevated risk of serious health consequences or fatal overdose, especially among specific group of users. The spectrum of BDZs and Z-drugs misuse is extended by new synthetic BDZs, which may pose high risks to users, since the majority have never undergone clinical trials or tests and consequently their pharmacology and toxicology are largely unknown.

29 September 2019 in Medicina
Verified
Journal Article
Open access
PDF file
DVDANIELE DE VITI
DANIELE DE VITI
AMAntonio Malvasi
Antonio Malvasi
Francesco P. Busardó Francesco P. Busardó
Francesco P. Busardó
RBRenata Beck
Renata Beck
Simona ZaamiSimona Zaami
Simona Zaami
Enrico MartinelliEnrico Martinelli
Enrico Martinelli
Background and objecives: Adverse cardiovascular outcomes during pregnancy have increased over the past few decades, with increased numbers of women delivering later in their reproductive life. Other factors include higher rates of female obesity, diabetes, hypertension, cardiovascular diseases and assisted reproductive technology, which has extended fertility. Those at risk require extensive prenatal maternal screening, constant pregnancy supervising, monitoring during labor, delivery and puerperium and careful anesthetic evaluation during delivery. Materials and Methods: The present review reports the relevant information available on cardiovascular outcomes in advanced maternal age delivering women and related medico-legal issues. The search was performed on Pubmed, Cochrane, Semantic Scholar, Medline and Embase databases, accessed by Ovid, including among others the terms “cardiomyopathy”, “ischaemic heart disease”, “arrhythmias”, “hypertension”, “peripartum period”, “diabetes”, “advanced maternal age” “anesthesia”, “maternal morbidity and mortality” and “litigation”. Results: To the extent that underestimating risk factors for peripartum cardiomyopathy (PPCM) can adversely impact maternal and fetal outcomes, the legal implications of misdiagnosis or mismanagement can result in high compensatory damages. Substantial indemnity payments drive up costs of insurance coverage. Conclusions: Multidisciplinary approaches are necessary from obstetricians, cardiologists, anesthesiologists and perinatologists for pregnancy monitoring and delivery outcomes.

27 March 2018 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
ADAlessandro D’aMbrosio
Alessandro D’aMbrosio
ACAntonella Cotoia
Antonella Cotoia
RBRenata Beck
Renata Beck
PSPotito Salatto
Potito Salatto
LZLada Zibar
Lada Zibar
GCGilda Cinnella
Gilda Cinnella
Impedance Cardiography (ICG) is a non-invasive tool for continuous hemodynamic monitoring. Aims of our study were to assess the utility of ICG to evaluate the hemodynamic impact of 6 mg (GL6) vs 8 mg (GL8) levobupivacaine combined with fentanyl in healthy patients undergoing elective cesarean section; secondary, to compare the duration and quality of analgesia and anesthesia. Sixty-two women receiving combined spinal-epidural (CSE) for elective cesarean delivery were randomly allocated to GL6 or GL8 groups. Mean arterial pressure (MAP), cardiac index (CI), systemic vascular resistance index (SVRI), heart rate (HR), stroke volume index (SVI) were recorded from Tbaseline to 31 min after CSE by ICG. Sensory and motor blocks, patients and surgeons satisfaction, neonatal data were also recorded. Fifteen of 32 patients in GL6 and 15 of 30 patients in GL8 experienced hypotension at T2 vs Tbaseline (P < .001) and SVRI reduction (P = .035 and P < .001 respectively). MAP, CI and SVRI were always slightly higher in GL6 vs GL8. HR and SVI remained stable until the end of surgery in all patients. Total ephedrine requirements was higher in GL8 (P = .010). The onset and offset time of sensory and motor block were similar in both groups, but the number of patients with motor block was lower in GL6 vs GL8 (P = .001). Patients and surgeon satisfaction scores, the number of patients needed systemic rescue doses, neonatal data were similar in both groups. ICG is a useful noninvasive tool to monitor continuously hemodynamics during cesarean section. The hemodynamic stability, the satisfying sensory block and rapid mobilization provided by low levobupivacaine dose may be particularly advantageous in obstetric patients. ClinicalTrials.gov: NCT03170427 . Retrospectively Registered (Date of registration: May 2017).